Skip to main content

Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study.

Publication ,  Conference
Gewandter, JS; Marshall, J; Brown, J; Curtis, LH; Dworkin, RH; Kleckner, I; Kolb, N; Morrow, GR; Mustian, KM; Mohile, SG
Published in: Journal of Clinical Oncology
May 20, 2018

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

e18707 / e18707

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gewandter, J. S., Marshall, J., Brown, J., Curtis, L. H., Dworkin, R. H., Kleckner, I., … Mohile, S. G. (2018). Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study. In Journal of Clinical Oncology (Vol. 36, pp. e18707–e18707). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.e18707
Gewandter, Jennifer S., James Marshall, Jeffrey Brown, Lesley H. Curtis, Robert H. Dworkin, Ian Kleckner, Noah Kolb, Gary R. Morrow, Karen Michelle Mustian, and Supriya Gupta Mohile. “Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study.” In Journal of Clinical Oncology, 36:e18707–e18707. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e18707.
Gewandter JS, Marshall J, Brown J, Curtis LH, Dworkin RH, Kleckner I, et al. Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e18707–e18707.
Gewandter, Jennifer S., et al. “Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study.Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. e18707–e18707. Crossref, doi:10.1200/jco.2018.36.15_suppl.e18707.
Gewandter JS, Marshall J, Brown J, Curtis LH, Dworkin RH, Kleckner I, Kolb N, Morrow GR, Mustian KM, Mohile SG. Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e18707–e18707.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

e18707 / e18707

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences